Logo Image
News
Academy
Publications
All PublicationseBooks
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademyShortsSponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Events
Webcasts
Event Calendar

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Events
  • Subscribe
  • Event Calendar
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos|
Clinical Operations & Strategy|
Patient Participation
Advertisement

Margo Michaels, MPH, ENACCT

Advertisement

Articles by Margo Michaels, MPH, ENACCT

i4-840068-1408526815305.jpg

Making a Difference in Cancer Trials Accrual

ByDebra Wujcik, PhD, RN, FAAN,Natasha Blakeney, MPH,Margo Michaels, MPH, ENACCT
April 1st 2014

Applied Clinical Trials

The integration of pre-screening all patients for eligibility in oncology studies.

table4-828006-1408529573898.png

Making a Difference in Clinical Trials Accrual: The Integration of Prescreening All Patients for Eligibility

ByDebra Wujcik, PhD, RN, FAAN,Natasha Blakeney, MPH,Margo Michaels, MPH, ENACCT
November 8th 2013

Applied Clinical Trials

Physician participation in and patient access to cancer treatment clinical trials (CCTs) are key measures for delivery of quality cancer care.

Advertisement

Latest Updated Articles

  • i4-840068-1408526815305.jpg
    Making a Difference in Cancer Trials Accrual

    April 1st 2014

  • table4-828006-1408529573898.png
    Making a Difference in Clinical Trials Accrual: The Integration of Prescreening All Patients for Eligibility

    November 8th 2013



Advertisement
Advertisement

Trending on Applied Clinical Trials Online

1

FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data

2

Beyond Patient Centricity: What Rare Disease Research Gets Right

3

Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal

4

AI Moves Patient Recruitment from Trial Bottleneck to Competitive Edge: A 2026 Perspective

5

ACT Brief: Human Readiness as Operational Foundation, Early Phase Capacity Consolidation, and AI-Driven Patient Matching Scale

  • About
  • Advertise
  • Contact Us
  • Editorial Contacts
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Applied Clinical Trials
  • BioPharm International
  • Cannabis Science and Technology
  • Chromatography Online
  • Nutritional Outlook
  • Pharmaceutical Commerce
  • Pharmaceutical Executive
  • Pharm Tech
  • Spectroscopy Online
  • Turbo Machinery Magazine
IS1
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us